How the treatment of ALL is changing
How new drugs are changing the landscape for transplant in lymphoma
The importance of anti-CD38 monoclonal antibodies for multiple myeloma
Immunotherapy for multiple myeloma: current research avenues
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.